Log in
Search
Links
This Site
Wageningen UR Site
Advanced Search
Information for
Education
Research
Publications
News & Calendar
About Wageningen University
Jobs at
Contact
Future BSc students
Future BSc German students
Future MSc students (Dutch)
Future MSc students (EU)
Future MSc students (non EU)
Future exchange students
PhD Candidates
Current MSc students
Alumni
BSc programmes
BSc minors
MSc programmes
PhD programmes
Courses and training
Chair Groups
International Education
Research at the University
Chair groups
Research domain
Rankings / Citation index
Specialisation
Research themes
Graduate schools
Professors
Research facilities
We@WUR
Wageningen UR publications
Library Wageningen UR
Corporate publications
News
Newsroom
Archive
RSS
Calendar
Mission and strategy
Organisation Chart
Domain
Board
Financial information
Van Hall Larenstein
History
Internationalisation @ WU
Wageningen Campus
Organisation
Number of students
Graduates
Students' origins
Working at Wageningen University
Vacancies
Internal vacancies
Active worldwide
Career
Conditions of Employment
Earning a doctorate
Tenure Track
Facilities
The town of Wageningen
Addresses
Route description and map Wageningen
Contacts and experts
A to Z - Questions and answers
wageningen ur (home)
>
wageningen university (home)
>
news & calendar
>
archive
>
calendar
>
2003
>
ir. w.f.h. sybesma : metabolic engineering of folate production in lactic acid bacteria
Ir. W.F.H. Sybesma : Metabolic Engineering of Folate Production in Lactic Acid Bacteria
News
Newsroom
Archive
Calendar
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
News
RSS
Calendar
Open days
Courses
Congresses and symposia
PhD-graduations and speeches
3 Oct 2003 16:00
Unit:
Wageningen University
Location:
Aula (gebouw 362), Gen. Foulkesweg 1, Wageningen
Promotor:
prof.dr. W.M. de Vos (Microbiology)
Co Promotor:
dr. J. Hugenholz
Folate is an essential compound in the human diet. Folate deficiency occurs frequently among certain population groups even in highly developed countries and may increase the risks for several diseases like neural tube defects, cardiovascular diseases and certain forms of cancer. The dairy starter bacterium Lactococcus lactis is able to synthesize this vitamin. The use of metabolic engineering has enabled the generation of a L. lactis strain with a more than 50-fold increased folate production. The synthesis of polyglutamyl folates and the associated release or retention of folate from or in the bacterial cell could be controlled by the expression levels of genes involved in folate biosynthesis and by the culture conditions. Moreover, the formation of monoglutamyl folate from polyglutamyl folate could enhance the bioavailability of folate, because folate is mainly consumed in the monoglutamyl form. In this thesis, we present the first animal trial on bioavailability of folates produced by genetically modified lactic acid bacteria. The outcome of this experiment forms the basis for a human clinical trial with these bacteria. Transformation of the entire folate gene cluster to a folate auxotroph Lactobacillus gasseri led to the production of folate in this bacterium and opens new avenues for the food industry to increase folate levels in fermented products. Further research on the production of vitamins in lactic acid bacteria has resulted in the development of a multivitamin producing L. lactis strain with increased production of folate and riboflavin. Such multivitamin producing strains could contribute to the development of nutrigenomics, facilitating a tailor made diet for individuals that have specific requirements for these two vitamins due to a genetic polymorphism. This research provides a basis for the development of functional foods with increased levels of vitamins that could be beneficial for health of the general population.
Print this activity
Disclaimer
General Terms and Conditions
Contact
All contents © 2011 Wageningen UR. All rights reserved.